• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    Novo Nordisk A/S (NVO)

    -NYSE
    45.16 1.28(2.92%) Jan 26, 4:03PM EST
    Add to Portfolio
    Prev Close:43.88
    Open:44.92
    Bid:45.46 x 800
    Ask:45.56 x 800
    1y Target Est:49.83
    Beta:0.99
    Next Earnings Date:N/A
    Day's Range:44.59 - 45.33
    52wk Range:37.21 - 49.11
    Volume:3,214,777
    Avg Vol (3m):1,542,750
    Market Cap:118.04B
    P/E (ttm):30.17
    EPS (ttm):1.50
    Div & Yield:0.61 (1.40%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVOUp 2.92%118.04B
    LLY77.13B
    PFE206.66B
    SNY122.63B

    Key Statistics

    Forward P/E (1 yr):24.02
    P/S (ttm):8.76
    Ex-Dividend Date:21-Mar-14

    Analysts

    Annual EPS Est (Dec-14) :1.64
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.93

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback